Ligand Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Amgen USD 1.69B 4M 2025-06
Arrowhead Research USD 30.95M 3.06M 2025-06
Baxter International USD 718M 15M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
Glaxosmithkline GBP 2.7B 632M 2024-12
Insmed USD 76.44M 71.11M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
Ligand Pharmaceuticals USD 20.18M 1.37M 2025-06
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.63B 104M 2025-06
Pacira USD 77.19M 9.58M 2025-06
Pfizer USD 3.42B 406M 2025-06
Veracyte USD 57.65M 1.51M 2025-06


Ligand Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.